Paperpal Prime Logo

Revista Medica de Chile : Impact Factor & More

eISSN: 0717-6163pISSN: 0034-9887

Key Metrics

CiteScore
1
Impact Factor
< 5
SNIP
0.36
Recommended pre-submission checks
Powered by Paperpal by Editage

Revista Medica de Chile Journal Specifications

Overview
Publisher SOC MEDICA SANTIAGO
Language Spanish
Frequency Monthly
General Details
LanguageSpanish
FrequencyMonthly
Publication Start Year1872
Website URLVisit website
View less

Planning to publish in Revista Medica de Chile ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revista Medica de Chile

Impact of Nutrition Education and Low-Protein Dietary Interventions on the Incidence and Progression of Chronic Kidney Disease.
  • 1 Aug 2026
  • Revista medica de Chile
Malignant Hypertension and Thrombotic Microangiopathy Induced by Cocaine Base Paste Use: A Case Report.
  • 1 Aug 2026
  • Revista medica de Chile
Use of a Desensitization Protocol in a Patient with Brentuximab Hypersensitivity: A Case Report from a Hospital in Rancagua, Chile.
  • 1 Aug 2026
  • Revista medica de Chile
Potential Role of BCL2 and BCL6 Overexpression in Circulating Tumor Cells as Molecular Biomarkers in DLBCL After R-CHOP Therapy.
  • 1 Aug 2026
  • Revista medica de Chile
Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.
  • 1 Aug 2026
  • Revista medica de Chile
The Challenge of Equity and Access in Chronic Wound Management: The Need to Integrate Advanced Technologies for Vulnerable Communities
  • 1 Aug 2026
  • Revista medica de Chile
Impact of Nutrition Education and Low-Protein Dietary Interventions on the Incidence and Progression of Chronic Kidney Disease.
  • 1 Aug 2026
  • Revista medica de Chile
Malignant Hypertension and Thrombotic Microangiopathy Induced by Cocaine Base Paste Use: A Case Report.
  • 1 Aug 2026
  • Revista medica de Chile
Use of a Desensitization Protocol in a Patient with Brentuximab Hypersensitivity: A Case Report from a Hospital in Rancagua, Chile.
  • 1 Aug 2026
  • Revista medica de Chile
Potential Role of BCL2 and BCL6 Overexpression in Circulating Tumor Cells as Molecular Biomarkers in DLBCL After R-CHOP Therapy.
  • 1 Aug 2026
  • Revista medica de Chile
Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.
  • 1 Aug 2026
  • Revista medica de Chile
The Challenge of Equity and Access in Chronic Wound Management: The Need to Integrate Advanced Technologies for Vulnerable Communities
  • 1 Aug 2026
  • Revista medica de Chile

FAQs on Revista Medica de Chile